Physician profile
Solomon Schwartzstein
NPI 1518046101
$1,080.94
in general payments reported to CMS, 2019-2025
11 companies · $163 in 2025
The $163 reported for 2025 was more than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $334 · 2020: $217 · 2021: $87.90 · 2022: $101 · 2023: $121 · 2024: $58.34 · 2025: $163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $342.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $341.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Sirona INC | $312.94 | 2019-2024 | Midwest Stylus Plus, Cavitron, Nupro |
| Straumann USA LLC | $162.54 | 2025 | |
| Southern Implants North America INC | $117.18 | 2019 | |
| Hu-Friedy Mfg. Co., LLC | $106.08 | 2019 | |
| Biohorizons Implant Systems INC. | $101.18 | 2022 | |
| Orapharma, A Division of Bausch Health US, LLC | $97.22 | 2019-2023 | Arestin |
| Align Technology, INC. | $90.10 | 2020 | |
| Philips North America LLC | $34.80 | 2019-2020 | |
| Henry Schein, INC. | $30.00 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $16.84 | 2023 | Seglentis |
| Ultradent Products INC | $12.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Solomon Schwartzstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.